Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Authors: Masatoshi Kudo, Ann‐Lii Cheng, Joong‐Won Park, Jae Hyung Park, Po‐Chin Liang, Hisashi Hidaka, Namiki Izumi, Jeong Heo, Youn Jae Lee, I‐Shyan Sheen, Chang‐Fang Chiu, Hitoshi Arioka, Satoshi Morita, Yasuaki Arai - The Lancet 2017 cited by 196